Technical Analysis for NSPR - InspireMD, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical NSPR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Crossed Above 20 DMA | Bullish | 0.00% |
| Jan 18 | Crossed Above 50 DMA | Bullish | 0.00% |
| Jan 18 | Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% |
| Jan 18 | Pocket Pivot | Bullish Swing Setup | 0.00% |
| Jan 18 | Volume Surge | Other | 0.00% |
| Jan 18 | Wide Range Bar | Range Expansion | 0.00% |
| Jan 18 | Wide Bands | Range Expansion | 0.00% |
| Jan 18 | Upper Bollinger Band Touch | Strength | 0.00% |
| Jan 17 | Fell Below 20 DMA | Bearish | 21.88% |
| Jan 17 | 180 Bearish Setup | Bearish Swing Setup | 21.88% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-06
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution
InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more NSPR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 9.17 |
| 52 Week Low | 0.13 |
| Average Volume | 1,233,578 |
| 200-Day Moving Average | 0.4898 |
| 50-Day Moving Average | 0.1875 |
| 20-Day Moving Average | 0.166 |
| 10-Day Moving Average | 0.1771 |
| Average True Range | 0.019 |
| ADX | 19.31 |
| +DI | 30.8041 |
| -DI | 15.251 |
| Chandelier Exit (Long, 3 ATRs ) | 0.167 |
| Chandelier Exit (Short, 3 ATRs ) | 0.187 |
| Upper Bollinger Band | 0.1974 |
| Lower Bollinger Band | 0.1346 |
| Percent B (%b) | 0.96 |
| BandWidth | 37.831325 |
| MACD Line | -0.0016 |
| MACD Signal Line | -0.0045 |
| MACD Histogram | 0.0029 |
| Fundamentals | Value |
|---|---|
| Market Cap | 1.45 Million |
| Num Shares | 7.45 Million |
| EPS | -2.45 |
| Price-to-Earnings (P/E) Ratio | -0.08 |
| Price-to-Sales | 1.52 |
| Price-to-Book | 0.53 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.29 | ||||
| Resistance 3 (R3) | 0.29 | 0.26 | 0.28 | ||
| Resistance 2 (R2) | 0.26 | 0.23 | 0.26 | 0.27 | |
| Resistance 1 (R1) | 0.23 | 0.22 | 0.24 | 0.23 | 0.26 |
| Pivot Point | 0.19 | 0.19 | 0.20 | 0.19 | 0.19 |
| Support 1 (S1) | 0.16 | 0.17 | 0.18 | 0.16 | 0.13 |
| Support 2 (S2) | 0.13 | 0.15 | 0.13 | 0.12 | |
| Support 3 (S3) | 0.10 | 0.13 | 0.12 | ||
| Support 4 (S4) | 0.10 |
